Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today announced the launch of the KINCISE 2™ Surgical Automated System, a next-generation automated power tool4,7,8* engineered to improve surgical efficiency5, provide control5,7 and aims to reduce physical burden on surgeons compared to manual impaction1,9‡ across both primary and revision hip, and revision knee replacement procedures..

强生医疗科技公司（Johnson & Johnson MedTech）是骨科技术和解决方案的全球领导者，今天宣布推出KINCISE 2™手术自动化系统，这是一种新一代的自动化电动工具，旨在提高手术效率、提供更好的控制，并相较于手动冲击，减轻外科医生在初次和翻修髋关节以及翻修膝关节置换手术中的体力负担。

Orthopaedic surgeons today face growing complexity in the operating room (OR), from longer procedures and increasing case volumes to the physical demands of surgery itself. Many procedures require repetitive, high-force tasks such as repeated mallet strikes, which have been linked to overuse injuries.

今天，骨科医生在手术室 (OR) 中面临日益复杂的挑战，从手术时间延长、病例数量增加到手术本身的体力要求。许多手术需要重复性的高力度操作，例如反复的锤击，这些操作已被证实与过度使用伤害有关。

97% of surgeons report musculoskeletal pain related to their work, commonly in the lower back, hands and neck.10 The KINCISE™ 2 System was developed to address these challenges head on, aiming to improve surgical efficiency5 and lessen the physical burden experienced by surgeons.1,9‡§.

97%的外科医生报告称，他们因工作而感到肌肉骨骼疼痛，常见部位为下背部、手部和颈部。KINCISE™ 2系统旨在直接应对这些挑战，力求提高手术效率，并减轻外科医生所承受的身体负担。

“When I think about what the KINCISE™ 2 System means for the future of orthopaedic care, it’s simple: it helps surgeons stay at their best, longer,” said Dr. Vasilios Mathews||, M.D., Texas Orthopedic Hospital. “This system is designed to reduce strain and support surgical precision, which means we can focus more fully on the patient in front of us.

“当我思考KINCISE™ 2系统对未来骨科护理的意义时，答案很简单：它帮助外科医生更长久地保持最佳状态，”德克萨斯骨科医院的瓦西里奥斯·马修斯博士说道。“该系统旨在减轻压力并支持手术精确性，这意味着我们可以更加专注于面前的患者。

That’s the true value – technology that not only improves surgical experience but helps us deliver better outcomes for every patient we treat.”.

这才是真正的价值所在——这项技术不仅提升了手术体验，还帮助我们为我们治疗的每位患者取得更好的治疗效果。”

KINCISE™ 2 builds on the consistent functionality of our first-generation KINCISE™ System. New design features—including increased reverse energy4 and push to lock adaptors7—provide an upgraded surgical workflow and experience.* The newest addition of Acetabular Cup Extraction makes the KINCISE™ 2 System the first and only automated impactor approved for removing well-fixed acetabular components5,11,12, expanding its role and versatility in complex hip revisions and complementing its compatibility with advanced techniques like Anterior Approach..

KINCISE™ 2 在我们第一代 KINCISE™ 系统的一致功能基础上进行了改进。新设计特性（包括增加的反向能量4和推锁适配器7）提供了升级的手术流程和体验。* 最新增加的髋臼杯提取功能使 KINCISE™ 2 系统成为首个且唯一获批用于移除固定良好的髋臼组件的自动化冲击器5,11,12，扩大了其在复杂髋关节翻修中的作用和多功能性，并与其对先进技术（如前路入路）的兼容性相辅相成。

“The KINCISE™ 2 System exemplifies the needs-based innovation we’re bringing to Orthopaedics this year,” said Aldo Denti, Company Group Chairman, Orthopaedics, Johnson & Johnson MedTech. “As more patients undergo joint replacements earlier in life, the demand for revision surgeries is rising. The KINCISE™ System has demonstrated the ability to help surgeons manage those complex cases by reducing operating time1,9‡§ and providing procedural control1,2,3* – ultimately supporting better outcomes for patients.

“KINCISE™ 2系统体现了我们今年为骨科领域带来的需求驱动创新，”强生医疗科技骨科公司集团主席阿尔多·邓蒂表示。“随着越来越多的患者在较年轻时接受关节置换手术，翻修手术的需求正在增加。KINCISE™ 系统已证明能够通过减少手术时间1,9‡§ 并提供手术控制1,2,3* 来帮助外科医生处理这些复杂病例，最终助力患者获得更好的治疗效果。"

¶**”.

¶**”。

Now commercially available in the United States, the KINCISE™ 2 System reflects Johnson & Johnson MedTech’s commitment to developing smarter, more adaptive technologies that address real challenges in orthopaedics, supporting surgeon performance, helping standardize care, and ultimately improving the surgical experience for patients and care teams alike.

目前，KINCISE™ 2 系统已在美国上市销售，这体现了强生医疗科技致力于开发更智能、更具适应性的技术，以应对骨科领域的实际挑战，支持外科医生的手术表现，帮助实现护理标准化，并最终改善患者和医护团队的手术体验。

For more information, visit https://www.jnjmedtech.com/en-US/campaign/kincise-2-system..

有关更多信息，请访问 https://www.jnjmedtech.com/en-US/campaign/kincise-2-system。

Orthopaedic Solutions from Johnson & Johnson MedTech

来自强生医疗科技的骨科解决方案

Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges. In Orthopaedics, we are on a mission to keep people moving by leveraging our deep expertise in joint reconstruction, robotics and enabling tech, spine, sports, trauma, and extremities, to develop the next generation of medtech solutions.

在强生公司，我们正在应对世界上最复杂和普遍的健康挑战。在骨科领域，我们致力于通过运用我们在关节重建、机器人技术及赋能科技、脊柱、运动医学、创伤和四肢方面的深厚专业知识，开发下一代医疗技术解决方案，以保持人们的活力。

We offer one of the most comprehensive Orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. For more, visit our website or follow us at @jjmt_ortho and on LinkedIn..

我们提供全球最全面的骨科产品组合之一，帮助我们服务的数百万患者恢复运动能力。欲了解更多信息，请访问我们的网站或在LinkedIn上关注我们@jjmt_ortho。

About Johnson & Johnson

关于约翰逊 & 约翰逊

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.

在强生，我们相信健康就是一切。我们在医疗创新方面的优势使我们能够构建一个世界，在这个世界中，复杂疾病得以预防、治疗和治愈，治疗方法更加智能且更少侵入性，解决方案也更加个性化。凭借我们在创新药物和医疗技术方面的专业知识，我们有能力在当今整个医疗解决方案领域进行创新，以实现明天的突破，并对人类健康产生深远影响。

Learn more about our MedTech sector’s global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn. DePuy Synthes Products, Inc. is a Johnson & Johnson company..

欲了解更多关于我们医疗技术领域在全球范围内的规模以及在心血管、骨科、外科和视力解决方案方面的深厚专业知识，请访问 https://thenext.jnjmedtech.com。关注我们的 LinkedIn 和 @JNJMedTech。DePuy Synthes Products, Inc. 是强生公司旗下企业。

Cautions Concerning Forward-Looking Statements

关于前瞻性陈述的注意事项

This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the KINCISE™ 2 Surgical Automation System. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events.

本新闻稿包含《1995年私人证券诉讼改革法案》中定义的关于KINCISE™ 2手术自动化系统的“前瞻性声明”。读者应注意不要依赖这些前瞻性声明。这些声明是基于对未来事件的当前预期。

If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment.

如果基本假设被证明不准确，或已知或未知的风险或不确定性成为现实，实际结果可能与强生公司的预期和预测大相径庭。风险和不确定性包括但不限于：商业成功的不确定性；专利面临的挑战；竞争，包括技术进步、竞争对手推出的新产品和获得的专利；生产困难和延误；产品疗效或安全问题导致的产品召回或监管行动；适用法律法规的变化，包括全球医疗改革；医疗产品和服务购买者的行为和支出模式的变化；以及控制医疗成本的趋势。

A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s most recent Annual Report on Form 10-K, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.

这些风险、不确定性和其他因素的进一步列表和描述，请参见强生公司最近的Form 10-K年度报告，包括标题为“关于前瞻性陈述的警示声明”和“项目1A. 风险因素”的部分，以及强生公司随后的Form 10-Q季度报告和其他提交给证券交易委员会的文件。

Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments..

这些文件的副本可在网上 www.sec.gov、www.jnj.com 获取，或应要求从 Johnson & Johnson 获取。Johnson & Johnson 不承担因新信息、未来事件或发展而更新任何前瞻性声明的责任。

© Johnson & Johnson and its affiliates 2025. All rights reserved. US_ORT_PWTL_401272.

© 强生公司及其关联公司2025年。保留所有权利。US_ORT_PWTL_401272。

Important Information: Prior to use, refer to the instructions for use supplied with the device(s) for indications, contraindications, side effects, warnings and precautions.

重要信息：使用前，请参阅设备附带的使用说明，了解适应症、禁忌症、副作用、警告和注意事项。

Footnotes:

脚注：

*Compared to KINCISE V1

*与KINCISE V1相比

†Based on a human performance study with simulated broaching

基于模拟钻孔的人体性能研究†

‡KINCISE V1

‡KINCISE V1

§Compared to manual impaction

与手动冲击相比

||Dr. Vasilios Mathews, M.D., is a paid consultant for Johnson & Johnson MedTech.

Vasilios Mathews博士，医学博士，是强生医疗科技的付费顾问。

¶Compared to a traditional mallet

与传统的木槌相比

**Based on a randomized controlled study: KINCISE (n=17) vs. mallet (n=18). Functional outcomes included hip function HOOS Survey (p=0.03), daily steps (p=0.04), walking distance (p=0.01) at 1-3 months post-operative.

基于一项随机对照研究：KINCISE（n=17）对比木槌（n=18）。功能结果包括术后1-3个月的髋关节功能HOOS调查（p=0.03）、每日步数（p=0.04）、行走距离（p=0.01）。

Ferrari E, Khan M, Mantel J, Wallbank R. The assessment of muscle fatigue in orthopedic surgeons, by comparing manual versus automated broaching in simulated total hip arthroplasty. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. 2021;235(12):1471-1478..

法拉利 E、汗 M、曼特尔 J、沃尔班克 R。通过在模拟全髋关节置换术中比较手动与自动扩孔来评估骨科医生的肌肉疲劳。《机械工程师学会会刊，H部分：医学工程杂志》。2021；235（12）：1471-1478。

DeCook CA. KINCISE™ Surgical Automated System: Surgical Tips and Pearls For Total Hip Arthroplasty. November 2019:1-1.1.

德库克 CA。KINCISE™ 外科自动系统：全髋关节置换术的手术技巧与要点。2019年11月：1-1.1。

DePuy Synthes. KINCISE System Acetabular Cup Extraction - Instructions For Use. 01/10/24. Windchill# 502088967.

德普伊辛thes。KINCISE系统髋臼杯取出 - 使用说明书。2024年1月10日。Windchill编号 502088967。

DePuy Synthes. KINCISE V1 - KINCISE V2 Comparison Report. 08/19/24. Windchill # 502047070.

DePuy Synthes. KINCISE V1 - KINCISE V2 对比报告。2024年8月19日。Windchill 编号 502047070。

DePuy Synthes. KINCISE V2 Design Validation & Summative Testing Method and Report. 18/08/24. Windchill# 501909014.

德普伊辛thes。KINCISE V2设计验证与总结性测试方法及报告。2024年8月18日。Windchill编号 501909014。

Johnson & Johnson MedTech. KINCISE 2, Human Performance Study Report. 19/12/2024. Windchill# 502146089.

强生医疗科技。KINCISE 2，人体性能研究报告。2024年12月19日。Windchill# 502146089。

Johnson & Johnson MedTech. KINCISE 2 Surgical Automated System - Instructions For Use. 2024. Agile SE_933224.

强生医疗科技。KINCISE 2 外科自动化系统 - 使用说明书。2024。Agile SE_933224。

Johnson and Johnson MedTech. KINCISE V2–Performance and Lifetime. 2024 Windchill 501439497.

强生医疗科技。KINCISE V2–性能与寿命。2024 Windchill 501439497。

Gordon D, Cardenas JM, Fawley D, Kitziger KJ, Gladnick BP. Mitigating calcar fracture risk with automated impaction during total hip arthroplasty. J Orthop. 2025;59:64-67.

戈登 D、卡德纳斯 JM、福利 D、基齐格 KJ、格拉迪克 BP。在全髋关节置换术中通过自动冲击减轻股骨颈骨折风险。《骨科杂志》。2025年；第59卷：64-67页。

McQuivey KS et al. Surgical Ergonomics and Musculoskeletal Pain in Orthopaedic Surgery Residents: A Multicenter Survey Study. J Am Acad Orthop Surg Glob Res Rev. 2021;5(3):e20.00119.

McQuivey KS 等。骨科住院医师的手术人体工程学与肌肉骨骼疼痛：一项多中心调查研究。《美国骨科医师学会全球研究综述杂志》。2021；5（3）：e20.00119。

Zimmer Biomet. HAMMR Operation and Maintence Guide. 2024. DOC0179252

齐默生物梅特。HAMMR操作与维护指南。2024。DOC0179252

Johnson & Johnson and its affiliates. KINCISE System Acetabular Cup Extraction - Instructions For Use. 01/10/24. Windchill# 502101159.

强生公司及其关联公司。KINCISE系统髋臼杯取出 - 使用说明。2024年1月10日。Windchill编号 502101159。

Media contacts:

媒体联系人：

Lindsey Diaz-MacInnis

林赛·迪亚兹-麦金尼斯

[email protected]

电子邮件地址

Abhi Basu

阿比·巴苏

[email protected]

[email protected]

Investor contact:

投资者联系方式：

Sandra Easton:

桑德拉·伊斯特伍德：

[email protected]

[email protected]

Source: jnj.com

来源：jnj.com